Literature DB >> 1550786

Myelokathexis treated with recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF).

U Hess1, A Ganser, H G Schnürch, G Seipelt, O G Ottmann, S Falk, G Schulz, D Hoelzer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1550786     DOI： 10.1111/j.1365-2141.1992.tb08910.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  10 in total

1.  Plerixafor for the Treatment of WHIM Syndrome.

Authors:  David H McDermott; Diana V Pastrana; Katherine R Calvo; Stefania Pittaluga; Daniel Velez; Elena Cho; Qian Liu; Hugh H Trout; João F Neves; Pamela J Gardner; David A Bianchi; Elizabeth A Blair; Emily M Landon; Susana L Silva; Christopher B Buck; Philip M Murphy
Journal:  N Engl J Med       Date:  2019-01-10       Impact factor: 91.245

2.  Oligoclonality, impaired class switch and B-cell memory responses in WHIM syndrome.

Authors:  Peter J Mc Guire; Charlotte Cunningham-Rundles; Hans Ochs; George A Diaz
Journal:  Clin Immunol       Date:  2010-03-11       Impact factor: 3.969

Review 3.  WHIM syndrome: congenital immune deficiency disease.

Authors:  Toshinao Kawai; Harry L Malech
Journal:  Curr Opin Hematol       Date:  2009-01       Impact factor: 3.284

4.  A report of WHIM syndrome (myelokathexis) - clinical features and bone marrow morphology.

Authors:  Flavio Augusto Naoum
Journal:  Rev Bras Hematol Hemoter       Date:  2011

5.  Pathogenesis, diagnosis and therapeutic strategies in WHIM syndrome immunodeficiency.

Authors:  Lauren E Heusinkveld; Erin Yim; Alexander Yang; Ari B Azani; Qian Liu; Ji-Liang Gao; David H McDermott; Philip M Murphy
Journal:  Expert Opin Orphan Drugs       Date:  2017-09-25       Impact factor: 0.694

6.  Effective stimulation of neutropoiesis with rh G-CSF in dyskeratosis congenita: a case report.

Authors:  L Oehler; E Reiter; J Friedl; E Kabrna; O A Haas; A Rosenkranz; K Lechner; K Geissler
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

Review 7.  WHIM syndrome: a defect in CXCR4 signaling.

Authors:  George A Diaz; A Virginia Gulino
Journal:  Curr Allergy Asthma Rep       Date:  2005-09       Impact factor: 4.919

8.  AMD3100 is a potent antagonist at CXCR4(R334X) , a hyperfunctional mutant chemokine receptor and cause of WHIM syndrome.

Authors:  David H McDermott; Joseph Lopez; Francis Deng; Qian Liu; Teresa Ojode; Haoqian Chen; Jean Ulrick; Nana Kwatemaa; Corin Kelly; Sandra Anaya-O'Brien; Mary Garofalo; Martha Marquesen; Dianne Hilligoss; Rosamma DeCastro; Harry L Malech; Philip M Murphy
Journal:  J Cell Mol Med       Date:  2011-10       Impact factor: 5.310

Review 9.  CXCR4, the master regulator of neutrophil trafficking in homeostasis and disease.

Authors:  Katia De Filippo; Sara M Rankin
Journal:  Eur J Clin Invest       Date:  2018-05-23       Impact factor: 4.686

10.  Description and outcome of a cohort of 8 patients with WHIM syndrome from the French Severe Chronic Neutropenia Registry.

Authors:  Sarah Beaussant Cohen; Odile Fenneteau; Emmanuel Plouvier; Pierre-Simon Rohrlich; Gerard Daltroff; Isabelle Plantier; Alain Dupuy; Delphine Kerob; Blandine Beaupain; Pierre Bordigoni; Fanny Fouyssac; Anne-Lise Delezoide; Gilles Devouassoux; Jean François Nicolas; Philippe Bensaid; Yves Bertrand; Karl Balabanian; Christine Bellanne Chantelot; Françoise Bachelerie; Jean Donadieu
Journal:  Orphanet J Rare Dis       Date:  2012-09-25       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.